You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 10,201,541


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,201,541
Title:Compositions and methods for treating HCV
Abstract: This disclosure is directed to pharmaceutical compositions that comprise two or more therapeutic agents that, inter alia, are useful for inhibiting hepatitis C virus (HCV) and methods for inhibiting HCV by co-administering two or more anti-HCV therapeutic agents.
Inventor(s): Collins; Christine A. (Skokie, IL), Cohen; Daniel E. (Highland Park, IL), Koev; Gennadiy (Libertyville, IL), Krishnan; Preethi (Gurnee, IL), Pilot-Matias; Tami J. (Green Oaks, IL)
Assignee: ABBVIE INC. (North Chicago, IL)
Application Number:15/398,390
Patent Claims: 1. A pharmaceutical composition comprising an amount of therapeutic agent A and an amount of therapeutic agent B, wherein therapeutic agent A is compound A or a salt thereof: ##STR00005## wherein therapeutic agent B is compound B or a salt thereof: ##STR00006## wherein the molar ratio of therapeutic agent A to therapeutic agent B is about 1:20 to about 1:2000.

2. The pharmaceutical composition of claim 1, wherein the amount of therapeutic agent B is about 200 mg.

3. The pharmaceutical composition of claim 1, wherein the amount of therapeutic agent A is from about 5 mg to about 200 mg.

4. The pharmaceutical composition of claim 1, wherein the composition further comprises one or more additional therapeutic agents.

5. The pharmaceutical composition of claim 4, wherein the one or more additional therapeutic agents include an HCV protease inhibitor.

6. The pharmaceutical composition of claim 5, wherein the one or more additional therapeutic agents include a cytochrome P-450 inhibitor.

7. The pharmaceutical composition of claim 1, further comprising an HCV protease inhibitor and a cytochrome P-450 inhibitor.

8. The pharmaceutical composition of claim 7, wherein the cytochrome P-450 inhibitor is ritonavir.

9. The pharmaceutical composition of claim 1, wherein therapeutic agent B is a sodium salt of compound B.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.